Publications by authors named "Boris Freydin"

Claim this Profile
Q
Quantification of spatial tumor heterogeneity in immunohistochemistry staining images.
Inna Chervoneva, Amy R Peck, Misung Yi, Boris Freydin, Hallgeir Rui

Bioinformatics· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling qRT-PCR dynamics with application to cancer biomarker quantification.
Inna Chervoneva, Boris Freydin, Terry Hyslop, Scott A Waldman

Stat Methods Med Res· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of tumor protein marker quantification by two independent automated immunofluorescence image analysis platforms.
Amy R Peck, Melanie A Girondo, Chengbao Liu, Albert J Kovatich, Jeffrey A Hooke, Boris Freydin

Mod Pathol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolactin-Stat5 signaling in breast cancer is potently disrupted by acidosis within the tumor microenvironment.
Ning Yang, Chengbao Liu, Amy R Peck, Melanie A Girondo, Alicia F Yanac, Boris Freydin

Breast Cancer Res· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimation of nonlinear differential equation model for glucose-insulin dynamics in type I diabetic patients using generalized smoothing.
Inna Chervoneva, Boris Freydin, Brian Hipszer, Tatiyana V Apanasovich, Jeffrey I Joseph

Ann Appl Stat· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomes.
Amy R Peck, Agnieszka K Witkiewicz, Chengbao Liu, Alexander C Klimowicz, Ginger A Stringer, Boris Freydin

Breast Cancer Res· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidermal growth factor receptor and insulinlike growth factor 1 receptor expression predict poor survival in pancreatic ductal adenocarcinoma.
Matias E Valsecchi, Mary McDonald, Jonathan R Brody, Terry Hyslop, Boris Freydin

Cancer· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased SIAH expression predicts ductal carcinoma in situ (DCIS) progression to invasive carcinoma.
Kathryn C Behling, Amy Tang, Boris Freydin, Inna Chervoneva, Sameep Kadakia

Breast Cancer Res Treat· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure.
Amy R Peck, Agnieszka K Witkiewicz, Chengbao Liu, Ginger A Stringer, Alexander C Klimowicz, Boris Freydin

J Clin Oncol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HuR status is a powerful marker for prognosis and response to gemcitabine-based chemotherapy for resected pancreatic ductal adenocarcinoma patients.
Nathan G Richards, David W Rittenhouse, Boris Freydin, Joseph A Cozzitorto, Dane Grenda

Ann Surg· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stromal CD10 and SPARC expression in ductal carcinoma in situ (DCIS) patients predicts disease recurrence.
Agnieszka K Witkiewicz, Boris Freydin, Inna Chervoneva, Magdalena Potoczek, Wendy Rizzo

Cancer Biol Ther· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis